文献速递关节外科

全踝关节置换术后假体周围骨溶解是翻修的危险因素:250例连续病例的单中心经验

Periprosthetic Osteolysis as a Risk Factor for Revision After Total Ankle Arthroplasty: A Single-Center Experience of 250 Consecutive Cases.
PubMed 文献 · J Bone Joint Surg Am · 2022-05-23

本研究纳入236例患者(250踝)行初次全踝关节置换术并使用活动衬垫HINTEGRA假体,平均随访83.5个月,分为骨溶解组(79踝)和无骨溶解组(171踝)。骨溶解发生率为31.6%,平均检出时间术后28.8个月,仅类风湿关节炎与骨溶解患病率增加显著相关(p=0.030),骨溶解患者所有临床结局变量在末次随访时均显著更低(p<0.05)。

要点

  • 全踝关节置换术后假体周围骨溶解发生率为31.6%,平均检出时间为术后28.8个月。
  • 骨溶解组所有临床结局变量在末次随访时均显著低于无骨溶解组(p<0.05)。
  • 仅类风湿关节炎与骨溶解患病率增加显著相关(p=0.030)。

核心结论

  • 全踝关节置换术后假体周围骨溶解的发生率相当高,且骨溶解的发生对临床结局产生负面影响。
  • 因此,预防和适当治疗骨溶解对于全踝关节置换术的满意长期生存至关重要。

研究设计与样本

  • 单中心经验,纳入236例患者(250踝)行初次全踝关节置换术并使用活动衬垫HINTEGRA假体,平均随访83.5个月(范围36至182个月)。
  • 将患者分为骨溶解组(79踝)和无骨溶解组(171踝),比较两组临床和影像学结局,并进行双变量逻辑回归分析以确定骨溶解的易感因素。

主要发现

  • 骨溶解组占250踝的31.6%,平均检出时间为术后28.8个月。
  • 骨溶解组中40踝接受密切监测而未行手术治疗,29踝接受植骨和聚乙烯内衬更换,剩余10踝接受翻修全踝关节置换术或关节融合术。
  • 末次随访时,骨溶解组所有临床结局变量均显著低于无骨溶解组(p<0.05)。
  • 在易感因素分析中,仅类风湿关节炎与骨溶解患病率增加显著相关(p=0.030)。

关键数值与推荐

  • 骨溶解组79踝(31.6%),无骨溶解组171踝。
  • 骨溶解平均检出时间为术后28.8个月。
  • 类风湿关节炎与骨溶解患病率增加显著相关(p=0.030)。
  • 末次随访时骨溶解组所有临床结局变量均显著低于无骨溶解组(p<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic osteolysis after total ankle arthroplasty (TAA) is a challenging problem. This study aimed to evaluate the prevalence of and predisposing factors for osteolysis and its effects on clinical outcomes. METHODS: We enrolled 236 patients (250 ankles) who underwent primary TAA using a mobile-bearing HINTEGRA prosthesis, with a mean follow-up of 83.5 months (range, 36 to 182 months), and subsequently divided them into 2 groups: the osteolysis group (79 ankles) and non-osteolysis group (171 ankles). Clinical and radiographic outcomes were compared between the 2 groups, and a bivariable logistic regression analysis was performed to identify predisposing factors for the development of osteolysis. RESULTS: In the osteolysis group (31.6% of the 250 ankles), the mean time of detection was 28.8 months postoperatively. Forty of these ankles were closely monitored without surgical treatment. Another 29 ankles underwent bone grafting and exchange of the polyethylene inlay, and the remaining 10 ankles underwent revision TAA or arthrodesis. All clinical outcome variables were significantly lower in patients with osteolysis, compared with those without osteolysis, at the final follow-up (p < 0.05). In the investigation of predisposing factors, only rheumatoid arthritis was identified as having a significant association with an increased prevalence of osteolysis (p = 0.030). CONCLUSIONS: This study demonstrated that the prevalence of periprosthetic osteolysis after TAA was considerable and that the development of osteolysis negatively affected the clinical outcome. Therefore, the prevention and appropriate treatment of osteolysis are crucial for the satisfactory long-term survival of TAA. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Lee GW, Lee KB. Periprosthetic Osteolysis as a Risk Factor for Revision After Total Ankle Arthroplasty: A Single-Center Experience of 250 Consecutive Cases. J Bone Joint Surg Am. 2022. PMID: 35930380. doi:10.2106/JBJS.21.01093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。